Search results
Results from the WOW.Com Content Network
A term for COVID-19 used by former United States president Donald Trump to emphasize that the pandemic started in China. Comirnaty. Main article: Comirnaty. The commercial name for the FDA approved COVID-19 vaccine from Pfizer, released August 21, 2021. It also has several other names or designators used on the actual vials. Community transmission
Just a few months ago, words like "social distancing" and "pandemic" rarely entered the daily lexicon across America. The changes have been so significant that Merriam-Webster announced it was ...
People who have severe cases of COVID-19 may experience lasting health problems, either from the virus itself or from certain drugs used to treat serious COVID-19, such as steroids and immune ...
“The older you get, the worse you do with viruses in general, but specifically with SARS-CoV-2,” he says. “Every time you get COVID-19 again and again, you increase the likelihood of having ...
ongoing symptomatic COVID-19 for effects from four to twelve weeks after onset, and; post-COVID-19 syndrome for effects that persist 12 or more weeks after onset. The clinical case definitions specify symptom onset and development. For instance, the WHO definition indicates that "symptoms might be new onset following initial recovery or persist ...
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic . The symptoms of COVID‑19 can vary but often include fever, [ 7 ] fatigue, cough, breathing difficulties , loss of smell , and loss of taste .
The COVID-19 vaccines are widely credited for their role in reducing the severity and death caused by COVID-19. [ 128 ] [ 129 ] As of March 2023, more than 5.5 billion people had received one or more doses [ 130 ] (11.8 billion in total) in over 197 countries.
A patient receives a dose of COVID-19 vaccine. The global case fatality rate from COVID-19 is approximately 1.4%. The global case fatality rate from H5N1, a viral infection, is approximately 52%.